title: Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review.
abstract: Chronic obstructive pulmonary disease (COPD) is a common disease among the elderly that could be prevented by smoking cessation. As it is characterized by airflow limitation that is not fully reversible, bronchodilator therapy is the first choice of treatment. Symptomatic COPD patients with or without risk for future exacerbations have a strong indication for the permanent use of long- and ultralong-acting β2-agonists and/or long-acting muscarinic antagonists. Combining bronchodilators is an effective approach, as they demonstrate synergic action at a cellular level and have additive clinical benefits and fewer adverse events compared with increased doses of the monocomponents. Novel fixed-dose combinations of long-acting β2-agonists/long-acting muscarinic antagonists in one inhaler have been approved for clinical use by the US Food and Drug Administration and the European Medicines Agency. This review focuses on published clinical trials about the fixed-dose combination of umeclidinium/vilanterol trifenatate in patients with COPD. Results from six studies (five of them of 12 weeks' duration and one that lasted 1 year, including more than 6,000 patients in total) showed that umeclidinium/vilanterol trifenatate improved lung function, dyspnea, and health-related quality of life and decreased the exacerbation rate with no serious adverse events. More longstanding trials are needed to evaluate the effect of the drug on disease progression and compare it directly with other fixed-dose combinations.
authors.affiliation: Pulmonary Department, "G Papanikolaou" Hospital, Aristotle University of Thessaloniki, Exohi, Thessaloniki, Greece.
authors.forename: Dionisios
authors.initials: D
authors.lastname: Spyratos
authors.affiliation: Pulmonary Department, "G Papanikolaou" Hospital, Aristotle University of Thessaloniki, Exohi, Thessaloniki, Greece.
authors.forename: Lazaros
authors.initials: L
authors.lastname: Sichletidis
keywords: COPD treatment; bronchodilators; long-acting muscarinic receptor antagonist combination; long-acting β2-agonists; lung function; umeclidinium/vilanterol
references.citation: Eur Respir J. 2005 Aug;26(2):214-22
references.pmid: 16055868
references.citation: Am J Respir Crit Care Med. 2005 May 1;171(9):972-7
references.pmid: 15665324
references.citation: Thorax. 2002 Oct;57(10):847-52
references.pmid: 12324669
references.citation: Lancet. 2009 Aug 29;374(9691):685-94
references.pmid: 19716960
references.citation: Eur Respir J. 2014 Jan;43(1):72-81
references.pmid: 23949963
references.citation: Pulm Pharmacol Ther. 2014 Oct;29(1):49-57
references.pmid: 25020273
references.citation: N Engl J Med. 2014 Oct 2;371(14):1285-94
references.pmid: 25196117
references.citation: Curr Clin Pharmacol. 2011 Feb;6(1):48-61
references.pmid: 21235463
references.citation: Pulm Pharmacol Ther. 2013 Feb;26(1):145-55
references.pmid: 22842340
references.citation: J Med Chem. 2010 Jun 10;53(11):4522-30
references.pmid: 20462258
references.citation: Thorax. 2005 Nov;60(11):925-31
references.pmid: 16055622
references.citation: Eur Respir J. 2009 May;33(5):1165-85
references.pmid: 19407051
references.citation: Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115
references.pmid: 24615270
references.citation: Eur Respir J. 2013 Nov;42(5):1391-401
references.pmid: 23645406
references.citation: Lancet. 2009 Oct 3;374(9696):1171-8
references.pmid: 19716598
references.citation: N Engl J Med. 2011 Sep 29;365(13):1184-92
references.pmid: 21991892
references.citation: Respir Res. 2014 Jul 08;15:77
references.pmid: 25005873
references.citation: Proc Am Thorac Soc. 2005;2(4):355-60; discussion 371-2
references.pmid: 16267362
references.citation: Eur Respir J. 2007 Sep;30(3):472-8
references.pmid: 17504798
references.citation: Lancet. 2005 Nov 26;366(9500):1875-81
references.pmid: 16310554
references.citation: Eur Respir J. 2011 Oct;38(4):789-96
references.pmid: 21349917
references.citation: Lancet. 2009 Aug 29;374(9691):695-703
references.pmid: 19716961
references.citation: Lancet. 2007 Sep 1;370(9589):741-50
references.pmid: 17765523
references.citation: Chest. 2012 Jul;142(1):119-27
references.pmid: 22241764
references.citation: BMC Pulm Med. 2014 Nov 18;14:178
references.pmid: 25404569
references.citation: Pulm Pharmacol Ther. 2012 Dec;25(6):465-71
references.pmid: 22955035
references.citation: Chest. 2014 May;145(5):981-91
references.pmid: 24385182
references.citation: Pulm Pharmacol Ther. 2013 Apr;26(2):256-64
references.pmid: 23232038
references.citation: PLoS Med. 2006 Nov;3(11):e442
references.pmid: 17132052
references.citation: Respir Med. 2012 Jul;106(7):989-97
references.pmid: 22483189
references.citation: Eur J Pharmacol. 2013 Feb 15;701(1-3):40-8
references.pmid: 23276660
references.citation: Thorax. 2013 Nov;68(11):1029-36
references.pmid: 24130228
references.citation: Respir Med. 2013 Oct;107(10):1538-46
references.pmid: 23830094
references.citation: Lancet Respir Med. 2014 Jun;2(6):472-86
references.pmid: 24835833
references.citation: Am J Respir Crit Care Med. 2012 Nov 15;186(10):975-81
references.pmid: 22997207
references.citation: Eur Respir J. 2012 Dec;40(6):1545-54
references.pmid: 22835613
references.citation: Respir Res. 2014 Jul 11;15:78
references.pmid: 25015176
references.citation: Adv Ther. 2010 Mar;27(3):150-9
references.pmid: 20411368
references.citation: Pulm Pharmacol Ther. 2014 Feb;27(1):29-37
references.pmid: 24269928
references.citation: Ther Adv Respir Dis. 2014 Dec;8(6):169-81
references.pmid: 25452426
references.citation: Eur Respir J. 2008 Oct;32(4):962-9
references.pmid: 18579551
references.citation: Eur Respir J. 2013 Dec;42(6):1484-94
references.pmid: 23722616
references.citation: Respir Res. 2013 Oct 07;14:100
references.pmid: 24093477
references.citation: Prim Care Respir J. 2013 Jun;22(2):161-8
references.pmid: 23460035
references.citation: N Engl J Med. 2007 Feb 22;356(8):775-89
references.pmid: 17314337
references.citation: Chest. 2002 May;121(5):1434-40
references.pmid: 12006425
references.citation: Respir Med. 2014 Dec;108(12):1752-60
references.pmid: 25458157
references.citation: Pulm Pharmacol Ther. 2010 Aug;23(4):257-67
references.pmid: 20381630